Advertisement

Evofem Biosciences, Inc. EVFM

Set alert

Price alert · EVFM

All alert types
0.01 USD 0.00 0.00%

At close · Oct 30

0.006 Day range 0.0063
0.001 52-week range 0.014
YTD
-40.00%
1 year
-50.00%
Open
0.0063
Prev close
0.006
Mkt cap
795.18K
Vol
14.92K
Avg vol
169.79K
EPS
-0.12
P/E
0.00
Div yield
0.00%
More statistics
Low
0.006
High
0.0063
Forward P/E
-0.48
Beta
-1.68
Short ratio
0.19
Inst. own
9.67%
Dividend
0.00
Ex-div date
50-d avg
0.74126
200-d avg
3.61
1y target
11.05

2Y chart

Chart tools
Interval

Events in this range
  • Nov 14, 2024Earnings: -0.02; estimate 0; surprise —%
Signals (186)
NameDateAgo
MACD: Sell SignalOct 29, 20262 days ago
MACD: Buy SignalOct 27, 20264 days ago
MACD: Sell SignalOct 14, 20262 weeks ago
SMA: BearishOct 13, 20262 weeks ago
MACD: Buy SignalOct 8, 20263 weeks ago
SMA: BullishOct 7, 20263 weeks ago
SMA: BearishOct 5, 20263 weeks ago
SMA: BullishOct 2, 20264 weeks ago
SMA: BearishSep 30, 20261 month ago
MACD: Sell SignalSep 30, 20261 month ago
SMA: BullishSep 29, 20261 month ago
MACD: Buy SignalSep 29, 20261 month ago
SMA: BearishSep 28, 20261 month ago
MACD: Sell SignalSep 28, 20261 month ago
SMA: BullishSep 21, 20261 month ago
MACD: Buy SignalSep 21, 20261 month ago
SMA: BearishSep 18, 20261 month ago
MACD: Sell SignalSep 18, 20261 month ago
SMA: BullishSep 16, 20261 month ago
MACD: Buy SignalSep 16, 20261 month ago
SMA: BearishSep 15, 20261 month ago
MACD: Sell SignalSep 15, 20261 month ago
MACD: Buy SignalSep 11, 20261 month ago
SMA: BullishSep 10, 20261 month ago
MACD: Sell SignalSep 8, 20261 month ago
MACD: Buy SignalAug 27, 20262 months ago
MACD: Sell SignalAug 24, 20262 months ago
MACD: Buy SignalAug 14, 20262 months ago
MACD: Sell SignalAug 12, 20262 months ago
MACD: Buy SignalAug 11, 20262 months ago
MACD: Sell SignalAug 10, 20262 months ago
SMA: BearishAug 7, 20262 months ago
SMA: BearishAug 7, 20262 months ago
SMA: BullishAug 6, 20262 months ago
SMA: BullishAug 6, 20262 months ago
MACD: Buy SignalAug 6, 20262 months ago
SMA: BearishJul 30, 20263 months ago
MACD: Sell SignalJul 13, 20263 months ago
SMA: BearishJul 8, 20263 months ago
SMA: BullishJul 7, 20263 months ago
MACD: Buy SignalJul 6, 20263 months ago
MACD: Sell SignalJul 2, 20264 months ago
MACD: Buy SignalJul 1, 20264 months ago
MACD: Sell SignalJun 30, 20264 months ago
SMA: BullishJun 17, 20264 months ago
SMA: BearishJun 16, 20264 months ago
SMA: BullishJun 12, 20264 months ago
SMA: BearishJun 11, 20264 months ago
SMA: BullishJun 3, 20265 months ago
MACD: Buy SignalMay 21, 20265 months ago
MACD: Sell SignalMay 19, 20265 months ago
MACD: Buy SignalMay 14, 20265 months ago
RSI: OversoldMay 5, 20265 months ago
SMA: BearishApr 30, 20266 months ago
MACD: Sell SignalApr 30, 20266 months ago
MACD: Buy SignalApr 29, 20266 months ago
SMA: BullishApr 28, 20266 months ago
SMA: BearishApr 27, 20266 months ago
SMA: BullishApr 24, 20266 months ago
SMA: BearishApr 21, 20266 months ago
MACD: Sell SignalApr 21, 20266 months ago
MACD: Buy SignalApr 7, 20266 months ago
SMA: BullishApr 6, 20266 months ago
SMA: BearishApr 2, 20267 months ago
MACD: Sell SignalApr 2, 20267 months ago
MACD: Buy SignalMar 27, 20267 months ago
SMA: BullishMar 25, 20267 months ago
MACD: Sell SignalMar 20, 20267 months ago
RSI: OversoldMar 20, 20267 months ago
SMA: BearishJan 29, 20269 months ago
SMA: BullishJan 28, 20269 months ago
MACD: Buy SignalJan 23, 20269 months ago
SMA: BearishDec 29, 202510 months ago
SMA: BearishDec 29, 202510 months ago
SMA: BullishDec 26, 202510 months ago
SMA: BearishDec 23, 202510 months ago
SMA: BullishDec 22, 202510 months ago
MACD: Sell SignalDec 18, 202510 months ago
SMA: BearishDec 16, 202510 months ago
SMA: BullishDec 11, 202510 months ago
SMA: BearishDec 4, 202511 months ago
SMA: BullishDec 3, 202511 months ago
SMA: BearishNov 25, 202511 months ago
SMA: BullishNov 24, 202511 months ago
SMA: BullishNov 18, 202511 months ago
MACD: Buy SignalNov 18, 202511 months ago
SMA: BearishNov 14, 202511 months ago
SMA: BullishNov 13, 202511 months ago
SMA: BearishNov 12, 202511 months ago
SMA: BullishNov 11, 202511 months ago
SMA: BearishNov 6, 202511 months ago
SMA: BullishNov 4, 202512 months ago
SMA: BearishNov 3, 202512 months ago
MACD: Sell SignalNov 3, 202512 months ago
SMA: BearishOct 31, 20251 year ago
MACD: Buy SignalOct 29, 20251 year ago
SMA: BullishOct 27, 20251 year ago
SMA: BullishOct 27, 20251 year ago
SMA: BearishOct 24, 20251 year ago
SMA: BullishOct 23, 20251 year ago
SMA: BearishOct 22, 20251 year ago
SMA: BearishOct 16, 20251 year ago
SMA: BullishOct 9, 20251 year ago
SMA: BearishOct 7, 20251 year ago
MACD: Sell SignalSep 30, 20251 year ago
RSI: OverboughtSep 12, 20251 year ago
MACD: Buy SignalSep 8, 20251 year ago
SMA: BullishSep 5, 20251 year ago
SMA: BullishSep 5, 20251 year ago
SMA: BearishSep 4, 20251 year ago
SMA: BearishSep 4, 20251 year ago
MACD: Sell SignalSep 4, 20251 year ago
SMA: BullishAug 25, 20251 year ago
SMA: BullishAug 25, 20251 year ago
SMA: BearishAug 22, 20251 year ago
SMA: BearishAug 22, 20251 year ago
SMA: BullishAug 19, 20251 year ago
MACD: Buy SignalAug 19, 20251 year ago
MACD: Sell SignalAug 18, 20251 year ago
SMA: BearishAug 15, 20251 year ago
SMA: BullishAug 14, 20251 year ago
MACD: Buy SignalAug 14, 20251 year ago
SMA: BearishAug 11, 20251 year ago
MACD: Sell SignalAug 11, 20251 year ago
SMA: BullishAug 8, 20251 year ago
MACD: Buy SignalAug 8, 20251 year ago
SMA: BearishAug 6, 20251 year ago
MACD: Sell SignalAug 6, 20251 year ago
SMA: BullishAug 5, 20251 year ago
MACD: Buy SignalAug 5, 20251 year ago
MACD: Sell SignalJul 31, 20251 year ago
SMA: BearishJul 30, 20251 year ago
SMA: BullishJul 24, 20251 year ago
MACD: Buy SignalJul 24, 20251 year ago
SMA: BearishJul 17, 20251 year ago
SMA: BullishJul 16, 20251 year ago
SMA: BearishJul 10, 20251 year ago
SMA: BullishJul 9, 20251 year ago
SMA: BearishJul 8, 20251 year ago
SMA: BullishJun 30, 20251 year ago
SMA: BearishJun 27, 20251 year ago
SMA: BullishJun 26, 20251 year ago
SMA: BearishJun 25, 20251 year ago
MACD: Sell SignalJun 24, 20251 year ago
MACD: Buy SignalJun 20, 20251 year ago
SMA: BullishJun 17, 20251 year ago
SMA: BearishJun 16, 20251 year ago
MACD: Sell SignalJun 16, 20251 year ago
SMA: BullishJun 5, 20251 year ago
SMA: BearishJun 4, 20251 year ago
SMA: BullishJun 2, 20251 year ago
MACD: Buy SignalMay 19, 20251 year ago
SMA: BullishMay 15, 20251 year ago
SMA: BearishMay 12, 20251 year ago
SMA: BullishMay 8, 20251 year ago
SMA: BearishMay 7, 20251 year ago
MACD: Sell SignalApr 23, 20251 year ago
MACD: Buy SignalApr 22, 20251 year ago
MACD: Sell SignalApr 16, 20251 year ago
MACD: Buy SignalApr 10, 20251 year ago
SMA: BullishApr 8, 20251 year ago
MACD: Sell SignalApr 8, 20251 year ago
SMA: BearishApr 7, 20251 year ago
SMA: BearishMar 24, 20251 year ago
SMA: BullishMar 21, 20251 year ago
MACD: Buy SignalMar 20, 20251 year ago
SMA: BearishFeb 19, 20251 year ago
MACD: Sell SignalFeb 19, 20251 year ago
SMA: BullishFeb 18, 20251 year ago
MACD: Buy SignalFeb 18, 20251 year ago
SMA: BearishFeb 11, 20251 year ago
MACD: Sell SignalFeb 11, 20251 year ago
SMA: BullishFeb 10, 20251 year ago
MACD: Buy SignalFeb 10, 20251 year ago
SMA: BearishFeb 6, 20251 year ago
MACD: Sell SignalFeb 6, 20251 year ago
MACD: Buy SignalFeb 5, 20251 year ago
SMA: BullishFeb 4, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishJan 31, 20251 year ago
SMA: BearishJan 30, 20251 year ago
MACD: Sell SignalJan 30, 20251 year ago
SMA: BullishJan 29, 20251 year ago
MACD: Buy SignalJan 29, 20251 year ago
SMA: BearishJan 28, 20251 year ago
MACD: Sell SignalJan 28, 20251 year ago

Key statistics

Market cap
27.34M
Enterprise value
137.13M
Trailing P/E
0.00
Forward P/E
-0.48
PEG ratio
0.00
Price / sales
1.76
Price / book
0.00
EPS (TTM)
-19.01
Beta
-1.68
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
15.57M
Revenue growth
224.90%
Free cash flow
68.23M
Total cash
19.89M
Total debt
125.74M
Return on equity
0.00%
Shares outstanding
85.46M
Short % of float
24.67%
50-day average
0.74126
200-day average
3.61

Analyst view

Consensus: buy

Buy
Price target (mean) 11.05 +184066.7% upside
Target (low)
0.75
Target (mean)
11.05
Target (high)
45.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.44.

Earnings history

Financials — quick view

All financials
EVFM Revenue — quarterly 5.81M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-09-302022-12-312023-03-31
EVFM Net income — quarterly -2.35M
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-09-302022-12-312023-03-31
EVFM EPS — quarterly -1.85
2019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-09-302022-12-312023-03-31

Earnings

EVFM recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-0.02——
Aug 14, 2024Jun 1, 20240.000.00——
May 15, 2024Mar 1, 20240.00-0.16——
Mar 27, 2024Dec 1, 20230.00-0.44——
Nov 14, 2023Sep 1, 20230.000.10——
Aug 14, 2023Jun 1, 20230.00-5.43——

Upgrades / downgrades

EVFM analyst upgrades and downgrades
DateFirmActionFromTo
Aug 15, 2022HC Wainwright & Co.main—Buy
Jul 15, 2022Morgan Stanleymain—Underweight
Jun 2, 2022Laidlaw & Co.init—Buy
May 25, 2022Piper Sandlermain—Overweight
May 11, 2022Morgan Stanleymain—Underweight
May 10, 2022Morgan Stanleymain—Underweight

About Evofem Biosciences, Inc.

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
evofem.com

News

Your note

Sign in to keep a note on EVFM — it syncs with the Stock Master app.

Insider holders

EVFM insider holders
InsiderRelationLatest transactionDateShares held
BARRANS RUSSELLOfficerPurchaseJun 10, 2021468,831
CULWELL KELLYOfficerStock Award(Grant)Feb 2, 2021315,451
FILE JUSTIN JChief Financial OfficerStock Award(Grant)Feb 17, 2022810,982
FITZPATRICK ALEXANDER A.General CounselStock Award(Grant)Feb 17, 2022516,422
HALL WILLIAM WALMSLEYDirectorPurchaseJun 14, 20205,000
INVESCO, LTD.Beneficial Owner of more than 10% of a Class of SecurityPurchaseJun 4, 20200

Institution ownership

EVFM institution ownership
Holder% heldSharesValueReported
Baker Brothers Advisors, LLC3.13%2,583,616826.50KJun 29, 2022
Alyeska Investment Group, L.p.2.37%1,950,607624.00KJun 29, 2022
Vanguard Group, Inc. (The)1.58%1,304,514417.31KJun 29, 2022
Citigroup Inc.0.89%736,406235.58KJun 29, 2022
Blackrock Inc.0.28%234,22574.93KJun 29, 2022
Citadel Advisors Llc0.25%210,12267.22KJun 29, 2022

Fund ownership

EVFM fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.14%260,67983.39KMar 30, 2022
Vanguard Extended Market Index Fund0.08%154,40449.39KMar 30, 2022
Fidelity Extended Market Index Fund0.07%59,26518.96KJun 29, 2022
Fidelity Total Market Index Fund0.02%14,3584.59KJun 29, 2022
Vanguard Institutional Index-Inst Total Stock Market Ind0.01%8,7912.81KJun 29, 2022
Fidelity Series Total Market Index Fund0.01%8,8312.83KJun 29, 2022
Advertisement